BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank M, Mayer E, Grünig E, Guth S. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res 2013;14:104. [PMID: 24107187 DOI: 10.1186/1465-9921-14-104] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sher Y. Psychiatric Aspects of Lung Disease in Critical Care. Crit Care Clin 2017;33:601-17. [PMID: 28601136 DOI: 10.1016/j.ccc.2017.03.014] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM. Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure. Circulation 2020;141:678-93. [PMID: 32091921 DOI: 10.1161/CIRCULATIONAHA.116.022362] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
3 Muntingh ADT, Gerritsen S, Batelaan NM, Bogaard HJ. Pathways to experiencing mental problems and need for mental support in patients with pulmonary arterial hypertension. Pulm Circ 2017;7:609-16. [PMID: 28730927 DOI: 10.1177/2045893217724750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
4 Verma S, Sahni S, Vijayan VK, Talwar A. Depression in pulmonary arterial hypertension: An undertreated comorbidity. Lung India 2016;33:58-63. [PMID: 26933309 DOI: 10.4103/0970-2113.173072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
5 Rawlings GH, Beail N, Armstrong I, Thompson AR. Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial. ERJ Open Res 2022;8:00526-2021. [DOI: 10.1183/23120541.00526-2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pfeuffer E, Krannich H, Halank M, Wilkens H, Kolb P, Jany B, Held M. Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung 2017;195:759-68. [PMID: 28993877 DOI: 10.1007/s00408-017-0052-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
7 Chao HY, Hsu CH, Wang ST, Yu CY, Chen HM. Mediating effect of social support on the relationship between illness concealment and depression symptoms in patients with pulmonary arterial hypertension. Heart Lung 2021;50:706-13. [PMID: 34107395 DOI: 10.1016/j.hrtlng.2021.03.082] [Reference Citation Analysis]
8 Caldarone F, Gebhardt P, Hoeper MM, Olsson KM, Fuge J, Park D, Meltendorf T, Kamp JC, Stapel B, Richter MJ, Gall H, Ghofrani HA, Kahl KG, Heitland I. Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension. Front Psychiatry 2022;13:812812. [DOI: 10.3389/fpsyt.2022.812812] [Reference Citation Analysis]
9 Ulrich S, Grunig E. The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment. Eur Respir J 2021;57:2004376. [DOI: 10.1183/13993003.04376-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bussotti M, Sommaruga M. Anxiety and depression in patients with pulmonary hypertension: impact and management challenges. Vasc Health Risk Manag 2018;14:349-60. [PMID: 30510427 DOI: 10.2147/VHRM.S147173] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
11 Olsson KM, Meltendorf T, Fuge J, Kamp JC, Park DH, Richter MJ, Gall H, Ghofrani HA, Ferrari P, Schmiedel R, Kulla HD, Heitland I, Lepsy N, Dering MR, Hoeper MM, Kahl KG. Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension. Front Psychiatry 2021;12:667602. [PMID: 34135787 DOI: 10.3389/fpsyt.2021.667602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ferrari P, Skåra H. My life with pulmonary arterial hypertension: a patient perspective. Eur Heart J Suppl 2019;21:K54-9. [PMID: 31857801 DOI: 10.1093/eurheartj/suz208] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tulloh RMR, Garratt V, Tagney J, Turner-Cobb J, Marques E, Greenwood R, Howard L, Gin-Sing W, Barton A, Ewings P, Craggs P, Hollingworth W. A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study. Pilot Feasibility Stud 2018;4:78. [PMID: 29796292 DOI: 10.1186/s40814-018-0270-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Rawlings GH, Beail N, Armstrong I, Condliffe R, Kiely DG, Sabroe I, Thompson AR. Adults' experiences of living with pulmonary hypertension: a thematic synthesis of qualitative studies. BMJ Open 2020;10:e041428. [PMID: 33293321 DOI: 10.1136/bmjopen-2020-041428] [Reference Citation Analysis]
15 Dobler CL, Krüger B, Strahler J, Weyh C, Gebhardt K, Tello K, Ghofrani HA, Sommer N, Gall H, Richter MJ, Krüger K. Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic. J Clin Med 2020;9:E4023. [PMID: 33322755 DOI: 10.3390/jcm9124023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sharma P, Morris NR, Adams L. Effect of experimental modulation of mood on perception of exertional dyspnea in healthy subjects. J Appl Physiol (1985) 2016;120:114-20. [PMID: 26565017 DOI: 10.1152/japplphysiol.00122.2015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
17 Church C, Gin-Sing W, Grady D, Johnson M, Kiely DG, Lordan J, Turner N, Wort SJ, Condliffe R. Establishing expert consensus for the optimal approach to holistic risk-management in pulmonary arterial hypertension: a Delphi process and narrative review. Expert Rev Respir Med 2021;:1-11. [PMID: 34018901 DOI: 10.1080/17476348.2021.1931129] [Reference Citation Analysis]
18 Tulloh R, Quek FF, Stevenson K, Garratt V, Turner-Cobb JM. Cortisol/cortisone levels and quality of life in individuals with pulmonary arterial hypertension. Pulm Circ 2020;10:2045894020924325. [PMID: 32523685 DOI: 10.1177/2045894020924325] [Reference Citation Analysis]
19 Zhou X, Shi H, Yang Y, Zhang Z, Zhai Z, Wang C. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey. Exp Ther Med 2020;19:3124-32. [PMID: 32256800 DOI: 10.3892/etm.2020.8566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Pandor A, Horner D, Davis S, Goodacre S, Stevens JW, Clowes M, Hunt BJ, Nokes T, Keenan J, de Wit K. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation. Health Technol Assess 2019;23:1-190. [PMID: 31851608 DOI: 10.3310/hta23630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Mujtaba SF, Sial JA, Karim M. Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Pak J Med Sci 2020;36:1100-5. [PMID: 32704297 DOI: 10.12669/pjms.36.5.1749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Banerjee D, Vargas SE, Guthrie KM, Wickham BM, Allahua M, Whittenhall ME, Palmisciano AJ, Ventetuolo CE. Sexual health and health-related quality of life among women with pulmonary arterial hypertension. Pulm Circ 2018;8:2045894018788277. [PMID: 30124126 DOI: 10.1177/2045894018788277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Halimi L, Marin G, Molinari N, Gamez AS, Boissin C, Suehs CM, Vachier I, Bourdin A. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension. J Psychosom Res 2018;105:45-51. [PMID: 29332633 DOI: 10.1016/j.jpsychores.2017.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
24 Mai AS, Lim OZH, Ho YJ, Kong G, Lim GEH, Ng CH, Ho C, Ho R, Lim Y, Kuntjoro I, Tay E, Yip J, Chew NWS, Low T. Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis. Front Med 2022;9:765461. [DOI: 10.3389/fmed.2022.765461] [Reference Citation Analysis]
25 Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Chron Respir Dis 2019;16:1479972318787906. [PMID: 30011997 DOI: 10.1177/1479972318787906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Takita Y, Takeda Y, Fujisawa D, Kataoka M, Kawakami T, Doorenbos AZ. Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study. BMJ Open Respir Res 2021;8:e000876. [PMID: 33926959 DOI: 10.1136/bmjresp-2021-000876] [Reference Citation Analysis]
27 Huang X, Li N, Pu Y, Zhang T, Wang B. Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives. Molecules 2019;24:E2939. [PMID: 31416121 DOI: 10.3390/molecules24162939] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
28 Park DH, Fuge J, Meltendorf T, Kahl KG, Richter MJ, Gall H, Ghofrani HA, Kamp JC, Hoeper MM, Olsson KM. Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension. Front Psychiatry 2021;12:668647. [PMID: 34248706 DOI: 10.3389/fpsyt.2021.668647] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Li Y, Wang R, Tang J, Chen C, Tan L, Wu Z, Yu F, Wang X. Progressive muscle relaxation improves anxiety and depression of pulmonary arterial hypertension patients. Evid Based Complement Alternat Med 2015;2015:792895. [PMID: 25922614 DOI: 10.1155/2015/792895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Wieteska-Miłek M, Szmit S, Florczyk M, Kuśmierczyk-Droszcz B, Ryczek R, Dzienisiewicz M, Torbicki A, Kurzyna M. Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic. J Clin Med 2021;10:4195. [PMID: 34575303 DOI: 10.3390/jcm10184195] [Reference Citation Analysis]
31 Myöhänen H, Vaheri A. Regulation and interactions in the activation of cell-associated plasminogen. Cell Mol Life Sci 2004;61:2840-58. [PMID: 15558213 DOI: 10.1007/s00018-004-4230-9] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.5] [Reference Citation Analysis]
32 Kolditz M, Seyfarth HJ, Wilkens H, Ewert R, Bollmann T, Dinter C, Hertel S, Klose H, Opitz C, Grünig E, Höffken G, Halank M. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH. Lung 2015;193:901-10. [PMID: 26363916 DOI: 10.1007/s00408-015-9802-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
33 Teixeira RB, Marins JCB, de Sá-junior AR, de Carvalho CJ, Lade CG, Rizvanov AA, Kiyasov AP, Mukhamedyarov MA, Palotás A, Lima LM. Psychological and Cognitive Profile of Hypertensive and Diabetic Patients. Journal of Nervous & Mental Disease 2015;203:781-5. [DOI: 10.1097/nmd.0000000000000367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Benjamin N, Marra AM, Eichstaedt C, Grünig E. Exercise Training and Rehabilitation in Pulmonary Hypertension. Heart Fail Clin 2018;14:425-30. [PMID: 29966639 DOI: 10.1016/j.hfc.2018.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ivarsson B, Ekmehag B, Sjöberg T. Support Experienced by Patients Living with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Heart Lung Circ 2016;25:35-40. [PMID: 26143540 DOI: 10.1016/j.hlc.2015.03.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Huppertz A, Werntz L, Meid AD, Foerster KI, Burhenne J, Czock D, Mikus G, Haefeli WE. Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided. Br J Clin Pharmacol 2018;84:2903-13. [PMID: 30192025 DOI: 10.1111/bcp.13757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
37 Fan VS, Meek PM. Anxiety, Depression, and Cognitive Impairment in Patients with Chronic Respiratory Disease. Clinics in Chest Medicine 2014;35:399-409. [DOI: 10.1016/j.ccm.2014.02.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
38 Dalla Vecchia LA, Bussotti M. Exercise training in pulmonary arterial hypertension. J Thorac Dis 2018;10:508-21. [PMID: 29600086 DOI: 10.21037/jtd.2018.01.90] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
39 Saglam M, Arikan H, Vardar-yagli N, Calik-kutukcu E, Inal-ince D, Savci S, Akdogan A, Yokusoglu M, Kaya EB, Tokgozoglu L. Inspiratory Muscle Training in Pulmonary Arterial Hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention 2015;35:198-206. [DOI: 10.1097/hcr.0000000000000117] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
40 Chen IC, Dai ZK. Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View. Acta Cardiol Sin 2015;31:507-15. [PMID: 27122915 DOI: 10.6515/acs20150424b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Mathai SC, Ghofrani HA, Mayer E, Pepke-Zaba J, Nikkho S, Simonneau G. Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J 2016;48:526-37. [PMID: 27076580 DOI: 10.1183/13993003.01626-2015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
42 Chia KS, Faux SG, Wong PK, Holloway C, Assareh H, McLachlan CS, Kotlyar E. Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol. BMJ Open 2017;7:e014037. [PMID: 28167746 DOI: 10.1136/bmjopen-2016-014037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
43 Lubberts B, Paulino Pereira NR, Kabrhel C, Kuter DJ, DiGiovanni CW. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost 2016;116:417-31. [PMID: 27362694 DOI: 10.1160/TH16-02-0152] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
44 Grünig E, Benjamin N, Krüger U, Kaemmerer H, Harutyunova S, Olsson KM, Ulrich S, Gerhardt F, Neurohr C, Sablotzki A, Halank M, Marra AM, Kabitz HJ, Thimm G, Fliegel KG, Klose H. General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 2018;272S:30-6. [PMID: 30190156 DOI: 10.1016/j.ijcard.2018.08.085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
45 Zhang J, Yin Y, Wen Y, Shi F, Wang J. Anxiety and Depression in Patients With Pulmonary Arterial Hypertension in Northwest China: A Cross-Sectional Study. Front Psychiatry 2022;12:758120. [DOI: 10.3389/fpsyt.2021.758120] [Reference Citation Analysis]
46 Gu S, Hu H, Dong H. Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension. PharmacoEconomics 2016;34:751-70. [DOI: 10.1007/s40273-016-0395-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
47 Bhat L, Hawkinson J, Cantillon M, Reddy DG, Bhat SR, Laurent CE, Bouchard A, Biernat M, Salvail D. RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats. Eur J Pharmacol 2017;810:92-9. [PMID: 28577964 DOI: 10.1016/j.ejphar.2017.05.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
48 Von Visger TT, Lee D, Lyons A, Chang YP. Integrated Review of Psychosocial and Behavioral Health Assessments and Interventions in Pulmonary Hypertension. Nurs Res 2021;70:150-61. [PMID: 33630538 DOI: 10.1097/NNR.0000000000000490] [Reference Citation Analysis]
49 Chiang YC, Hu LY, Couper J, Cheng CC, Wang LH, Huang WC, Lu T. Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study. Pulm Circ 2018;8:2045894018787479. [PMID: 29916763 DOI: 10.1177/2045894018787479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Zhang M, Zhang W, Liu Y, Wu M, Zhou J, Mao Z. Relationship between Family Function, Anxiety, and Quality of Life for Older Adults with Hypertension in Low-Income Communities. Int J Hypertens 2021;2021:5547190. [PMID: 34616569 DOI: 10.1155/2021/5547190] [Reference Citation Analysis]
51 Dering M, Lepsy N, Fuge J, Meltendorf T, Hoeper MM, Heitland I, Kamp JC, Park D, Richter MJ, Gall H, Ghofrani HA, Ellermeier D, Kulla H, Kahl KG, Olsson KM. Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension. Front Psychiatry 2022;13:821466. [DOI: 10.3389/fpsyt.2022.821466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]